$138.34 Million in Sales Expected for Tivity Health Inc (TVTY) This Quarter

Equities research analysts expect Tivity Health Inc (NASDAQ:TVTY) to post $138.34 million in sales for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for Tivity Health’s earnings. The highest sales estimate is $138.70 million and the lowest is $137.69 million. Tivity Health reported sales of $124.93 million in the same quarter last year, which indicates a positive year over year growth rate of 10.7%. The company is scheduled to announce its next earnings results on Thursday, February 22nd.

According to Zacks, analysts expect that Tivity Health will report full year sales of $138.34 million for the current financial year, with estimates ranging from $555.20 million to $556.30 million. For the next fiscal year, analysts expect that the business will report sales of $615.82 million per share, with estimates ranging from $606.10 million to $620.23 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover Tivity Health.

Tivity Health (NASDAQ:TVTY) last posted its quarterly earnings results on Thursday, October 26th. The company reported $0.46 EPS for the quarter, beating the consensus estimate of $0.36 by $0.10. The firm had revenue of $137.70 million during the quarter, compared to analysts’ expectations of $137.95 million. Tivity Health had a return on equity of 30.23% and a net margin of 11.45%. The company’s revenue for the quarter was up 10.2% on a year-over-year basis.

Several equities analysts have commented on the company. BidaskClub cut Tivity Health from a “buy” rating to a “hold” rating in a report on Thursday. Chardan Capital reaffirmed a “neutral” rating and issued a $44.00 price target (up previously from $40.00) on shares of Tivity Health in a report on Friday, October 27th. Zacks Investment Research reaffirmed a “sell” rating on shares of Tivity Health in a report on Saturday. Barrington Research reaffirmed an “outperform” rating and issued a $40.00 price target (down previously from $46.00) on shares of Tivity Health in a report on Tuesday, November 7th. Finally, ValuEngine cut Tivity Health from a “buy” rating to a “hold” rating in a report on Monday, November 6th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $46.25.

In other news, Director Conan Laughlin sold 115,087 shares of the stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $33.87, for a total value of $3,897,996.69. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Mary Flipse sold 5,000 shares of the stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $48.11, for a total value of $240,550.00. Following the completion of the transaction, the insider now directly owns 45,167 shares of the company’s stock, valued at $2,172,984.37. The disclosure for this sale can be found here. Over the last three months, insiders sold 875,892 shares of company stock valued at $31,815,642. 8.42% of the stock is currently owned by insiders.

Institutional investors and hedge funds have recently modified their holdings of the company. Flinton Capital Management LLC raised its holdings in shares of Tivity Health by 63.5% in the 2nd quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock worth $139,000 after buying an additional 1,360 shares in the last quarter. Riverhead Capital Management LLC raised its holdings in shares of Tivity Health by 69.7% in the 2nd quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock worth $142,000 after buying an additional 1,464 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of Tivity Health in the 3rd quarter worth approximately $210,000. Crossmark Global Holdings Inc. acquired a new position in shares of Tivity Health in the 3rd quarter worth approximately $279,000. Finally, Piedmont Investment Advisors LLC acquired a new position in shares of Tivity Health in the 2nd quarter worth approximately $290,000.

Tivity Health (NASDAQ:TVTY) traded down $0.05 during trading on Monday, reaching $36.30. The company’s stock had a trading volume of 313,759 shares, compared to its average volume of 418,520. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.60 and a current ratio of 0.60. The firm has a market cap of $1,440.07, a PE ratio of 24.53, a price-to-earnings-growth ratio of 1.94 and a beta of 0.18. Tivity Health has a 12-month low of $20.60 and a 12-month high of $48.50.

COPYRIGHT VIOLATION NOTICE: “$138.34 Million in Sales Expected for Tivity Health Inc (TVTY) This Quarter” was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.com-unik.info/2018/01/08/138-34-million-in-sales-expected-for-tivity-health-inc-tvty-this-quarter.html.

About Tivity Health

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Get a free copy of the Zacks research report on Tivity Health (TVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tivity Health (NASDAQ:TVTY)

What are top analysts saying about Tivity Health? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Tivity Health and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit